Onychomycosis Treatment Market Outlook 2026-2034: by Treatment Type (Device-based Treatments, Medication-Based Treatment, Allylamines, Azoles, Other Classes), Disease Type, Pathogen Type

The Onychomycosis Treatment Market is estimated at US$3.4 billion in 2026 and is projected to grow at a CAGR of 3.9% to reach US$4.6 billion by 2034.

Market Overview

The Global Onychomycosis Treatment Market covers therapies used to treat fungal nail infections through topical, oral, device based, and supportive care approaches across medical and consumer channels.

Relevant uses and settings include dermatology care, podiatry treatment, retail pharmacy, topical therapies, oral prescriptions, and clinical nail restoration support. Commercial considerations include slow treatment response, recurrence risk, adherence difficulty, and competition among topical, oral, and procedural approaches with mixed patient expectations.

Market Segmentation

By Treatment Type

• Device-based Treatments
• Medication-Based Treatment
• Allylamines
• Azoles
• Other Classes

By Disease Type

• Distal Subungual Onychomycosis
• White Superficial Onychomycosis
• Proximal Subungual Onychomycosis
• Total Dystrophic Onychomycosis

By Pathogen Type

• Dermatophytes
• Non-dermatophyte Molds
• Yeasts

Key Companies Analysed

• Bausch Health
• Kaken Pharmaceutical
• Pfizer
• Johnson & Johnson
• Galderma
• Bayer
• Novartis
• Sun Pharmaceutical
• Dr. Reddy's Laboratories
• Cipla
• Taro Pharmaceutical
• Almirall
• Moberg Pharma
• Lumenis
• L'Oréal
• Perrigo
• Teva Pharmaceutical Industries
• LEO Pharma
• Glenmark
• F. Hoffmann-La Roche

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.